Angiopoietin
Antagonists: Angiopoietin 2
Kinase inhibitors:
Rebastinib
Antibodies: Evinacumab (against angiopoietin 3)
Nesvacumab (against angiopoietin 2)
CNTF EGF (ErbB)
EGF(ErbB1/HER1) ErbB2/HER2
Kinase inhibitors: Afatinib
Lapatinib
Mubritinib
Neratinib
Tucatinib
ErbB3/HER3 ErbB4/HER4
FGF
FGFR1 FGFR2
Agonists:
FGF (1 , 2 (bFGF) , 3 , 4 , 5 , 6 , 7 (KGF ), 8 , 9 , 10 (KGF2) , 17 , 18 , 22 )
Palifermin
Selpercatinib
Sprifermin
Trafermin
Kinase inhibitors: Infigratinib
FGFR3
Antibodies: Burosumab (against FGF23)
FGFR4 Unsorted
HGF (c-Met)
Agonists :
Hepatocyte growth factor
IGF
IGF-1
Kinase inhibitors:
Linsitinib
IGF-2
Agonists : Insulin-like growth factor-2 (somatomedin A)
Others
Cleavage products/derivatives with unknown target:
Trofinetide
LNGF (p75NTR )
Antagonists:
Dexamethasone
Testosterone
PDGF RET (GFL)
SCF (c-Kit) TGFβ Trk
TrkA
Antagonists:
Dexamethasone
FX007
Testosterone
Negative allosteric modulators:
Kinase inhibitors:
Entrectinib
K252a
Larotrectinib
Lestaurtinib
Rebastinib
)
TrkB TrkC
VEGF
Decoy receptors: Aflibercept
Others
Additional growth factors: Adrenomedullin
Colony-stimulating factors (see here instead)
Connective tissue growth factor (CTGF)
Ephrins (A1 , A2 , A3 , A4 , A5 , B1 , B2 , B3 )
Erythropoietin (see here instead)
Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)
Glia maturation factor (GMF)
Hepatoma-derived growth factor (HDGF)
Interleukins /T-cell growth factors (see here instead)
Leukemia inhibitory factor (LIF)
Macrophage-stimulating protein (MSP; HLP, HGFLP)
Midkine (NEGF2)
Migration-stimulating factor (MSF; PRG4)
Oncomodulin
Pituitary adenylate cyclase-activating peptide (PACAP)
Pleiotrophin
Renalase
Thrombopoietin (see here instead)
Wnt signaling proteins
Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)